³Ô¹ÏÍøÕ¾

Latest therapeutics News | Page 7

Chimeric Therapeutics announces new trial for CHM 1101 in glioblastoma
Elizabeth Johnson wins inaugural Schwartz visionary grant
Major development for cancer-killing ‘Masterswitch’ discovery
Kazia Therapeutics participates in ‘Cancer Moonshot Brain Cancers’ forum
Best early-stage project at awarded at AusMedtech 2023
AI drug discovery will power collaboration with Pharos Therapeutics
Funnel-web spider venom varies
KAZIA CEO, DR JOHN FRIEND PARTICIPATES IN WHITE HOUSE CANCER MOONSHOT FORUM Brain Cancers Forum on Glioblastoma & Diffuse Intrinsic Pontine Glioma Forum
CSIRO launches free SME programme
Brightest minds power quest for brain cancer cure
$3.4M grant to tackle ‘biggest challenge’ to HIV cure
Strengthening influenza preparedness through OpenWHO online course
Researchers Modify Drug to Enter Cells and Treat Pain
New human epigenetics laboratory
Chimeric Therapeutics announces new capital raise
New report calls on national cell and gene therapy plan
Release of Te Rau Ora Equity Review
Funding for early screening and improved treatments for deadly lung disease
Amplia Therapeutics says third cohort enrolment completed in ACCENT clinical trial
UWA and Bridgewest Perth Pharma announce new partnership
LBT Innovations begins search for new board chair
Antisense Therapeutics announces the appointment of new CEO and managing director
Sydney spinout lands $273m deal to develop drugs for psychiatric disorders
Patent granted in India and Notice of Allowance Issued in Israel for CLTX Car Technology
World-changing research on show at inaugural symposium
How microbiome affects immune system
Could medicinal cannabis be answer to pain of endometriosis?
New survey results show health systems starting to recover from pandemic
Cytiva supports BioCina with first GMP production and development facility for mRNA
HKUST Sweeps 20 awards at 48th International Exhibition of Inventions Geneva
Micro/nano research makes big impact on life-changing technology
Telix reports its first quarter of $100 million in revenue
University spinout Complement Therapeutics secures €72 million to tackle diseases including leading cause of blindness
Slippery slope – basic research underfunded in Australia
Health Policy Symposium: What is future of medicine?
Cynata receives ethics approval for proposed aGvHD Phase 2 clinical trial
American Gastroenterological Association invests in unsedated transnasal endoscopy medical device company, EvoEndo®
Improving access to novel COVID-19 treatments
Member spotlight: Meet Dr Leanne Teoh
How Virtual Reality Can Help Relieve Chronic Pain
New strategy to prevent cardiovascular disease hidden in toxic waste product
Social solution – rare ovarian cancer insights
Chimeric Therapeutics reports ‘positive feedback’ on plan for CHM 2101
New funding will boost RNA research into vaccines and other healthcare treatments
New way to study molecular drivers of cancer
Antibody fragment-nanoparticle therapeutic eradicates cancer
New technology maps where and how cells read their genome
Clinical trial success for psoriasis drug